Patient Resources

Cancer Care Information for Patients & Caregivers in Singapore

Explore articles on cancer care, including diagnosis, treatment, and supportive care in Singapore. These resources provide general information to help patients and caregivers better understand their journey and support discussions with their healthcare team.

Filter by:
Cancer Types
Other Topics
Through the media, we have heard about the number one cancer in Singapore – colorectal cancer, which refers to the cancer of the colon or rectum. Due to the high prevalence of this disease, we may know of someone or heard of someone diagnosed with colorectal cancer. According to data from the Ministry of Health in Singapore, colon cancer is the most common cancer in males and the second most common in females.
It is no secret that Singaporeans love spicy food. From the tongue-numbing Ma La originating from Chongqing, China to spicy sambal from our favourite Nasi Padang stalls, spice is almost essential for our daily meals here on this sunny island. While spice elevates our food, is it really good for our health to consume spicy food on the regular?
The kidneys are two bean-shaped organs located just below the rib cage, one on each side of your spine. Healthy kidneys filter blood to remove waste and extra water to make urine.
The Food and Drug Administration (FDA) recently approved two new treatments for recurrent or metastatic (cancer spread to other parts of the body) cervix cancers.
One of the eye catching topics at the recent World Conference on Lung Cancer (WCLC) was about training dogs to sniff out malignant lung cancer nodules. The World Conference on Lung Cancer is the world’s largest meeting involving lung cancer specialists, researchers, doctors, from many countries, discussing about lung cancer and other thoracic malignancies. Several doctors from OncoCare Care Cancer Centre (Singapore) attended the meeting in September 2018.
The approach to management of advanced lung cancer has undergone a remarkable transformation over the past decade. This is due to the availability of a number of targeted agents in treatment of molecularly driven lung cancer subsets; as well as availability of immunotherapy agents.